ATM and cancer: We reviewed the patients seen in our hereditary cancer clinic who had undergone comprehensive multigene panel testing and were found to be heterozygous for a germline pathogenic variant in ATM. A total of thirty-one patients met these criteria, none of which had a pathogenic variant in any other hereditary cancer gene.